Strain Differences and Effects of Environmental Manipulation on Astrocytes (Glial Fibrillary Acidic Protein), Glucocorticoid Receptor, and Microglia (Iba1) Immunoreactivity between Wistar-Kyoto and Wistar Females
Abstract:Background: Depression is often associated with an increase in hypothalamic-pituitary-adrenal (HPA) axis reactivity and immune response. To investigate this relationship, we examined the consequences of environmental manipulation on the neural correlates of the HPA axis and immune response in an animal model of depression, the Wistar-Kyoto (WKY) rat. Additionally, female animals are often overlooked in preclinical research because of the hormone fluctuations inherent in the estrous cycle. Methods: Female rats … Show more
“…The possible impaired negative feedback in WKY rats does not appear to be due to a downregulation of glucocorticoid receptors (GRs) [ 81 , 82 ]. In contrast, increased GR staining in the hippocampus of WKY females compared to Wistars, and increased expression of hippocampal Nr3c1 (GR) in WKYs compared to SD, suggest upregulation of GRs in WKYs [ 101 , 102 ]. The upregulation of hippocampal GR in the WKYs parallels the antidepressant effects of glucocorticoid synthesis inhibitors and GR antagonists [ 103 - 105 ], while the findings of GR downregulation could be specific to peripheral cells in major depressive disorder (MDD) individuals [ 99 ].…”
There is an ongoing debate about the value of animal research in psychiatry with valid lines of reasoning stating the limits of individual animal models compared to human psychiatric
illnesses. Human depression is not a homogenous disorder; therefore, one cannot expect a single
animal model to reflect depression heterogeneity. This limited review presents arguments that
the Wistar Kyoto (WKY) rats show intrinsic depression traits. The phenotypes of WKY do not
completely mirror those of human depression but clearly indicate characteristics that are
common with it. WKYs present despair-like behavior, passive coping with stress, comorbid
anxiety, and enhanced drug use compared to other routinely used inbred or outbred strains of
rats. The commonly used tests identifying these phenotypes reflect exploratory, escape-oriented,
and withdrawal-like behaviors. The WKYs consistently choose withdrawal or avoidance in novel
environments and freezing behaviors in response to a challenge in these tests. The physiological
response to a stressful environment is exaggerated in WKYs. Selective breeding generated two
WKY substrains that are nearly isogenic but show clear behavioral differences, including that of
depression-like behavior. WKY and its substrains may compare characteristics of subgroups of
depressed individuals with social withdrawal, low energy, weight loss, sleep disturbances, and
specific cognitive dysfunction. The genomes of the WKY and WKY substrains contain
variations that impact the function of many genes identified in recent human genetic studies of
depression. Thus, these strains of rats share characteristics of human depression at both
phenotypic and genetic levels, making them a model of depression traits.
“…The possible impaired negative feedback in WKY rats does not appear to be due to a downregulation of glucocorticoid receptors (GRs) [ 81 , 82 ]. In contrast, increased GR staining in the hippocampus of WKY females compared to Wistars, and increased expression of hippocampal Nr3c1 (GR) in WKYs compared to SD, suggest upregulation of GRs in WKYs [ 101 , 102 ]. The upregulation of hippocampal GR in the WKYs parallels the antidepressant effects of glucocorticoid synthesis inhibitors and GR antagonists [ 103 - 105 ], while the findings of GR downregulation could be specific to peripheral cells in major depressive disorder (MDD) individuals [ 99 ].…”
There is an ongoing debate about the value of animal research in psychiatry with valid lines of reasoning stating the limits of individual animal models compared to human psychiatric
illnesses. Human depression is not a homogenous disorder; therefore, one cannot expect a single
animal model to reflect depression heterogeneity. This limited review presents arguments that
the Wistar Kyoto (WKY) rats show intrinsic depression traits. The phenotypes of WKY do not
completely mirror those of human depression but clearly indicate characteristics that are
common with it. WKYs present despair-like behavior, passive coping with stress, comorbid
anxiety, and enhanced drug use compared to other routinely used inbred or outbred strains of
rats. The commonly used tests identifying these phenotypes reflect exploratory, escape-oriented,
and withdrawal-like behaviors. The WKYs consistently choose withdrawal or avoidance in novel
environments and freezing behaviors in response to a challenge in these tests. The physiological
response to a stressful environment is exaggerated in WKYs. Selective breeding generated two
WKY substrains that are nearly isogenic but show clear behavioral differences, including that of
depression-like behavior. WKY and its substrains may compare characteristics of subgroups of
depressed individuals with social withdrawal, low energy, weight loss, sleep disturbances, and
specific cognitive dysfunction. The genomes of the WKY and WKY substrains contain
variations that impact the function of many genes identified in recent human genetic studies of
depression. Thus, these strains of rats share characteristics of human depression at both
phenotypic and genetic levels, making them a model of depression traits.
“…This suggests that the significant increase in CORT levels previously seen may be due to hyperactivity of the HPA axis when handling and/or blood sampling. That being said, studies have reported altered density of GRs in the WKY rat 34,35 and decreased GR function contributes to HPA axis hyperactivity and the development of depressive symptoms, 36 which may account for the depressive‐like phenotype seen in these rats.…”
Over 50% of depressed patients show hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis. Conventional therapy takes weeks to months to improve symptoms. Ketamine has rapid onset antidepressant effects. Yet its action on HPA axis activity is poorly understood. Here, we measured the corticosterone (CORT) response to ketamine administered at different times of day in the Wistar-Kyoto (WKY) rat. In male rats, blood was collected every 10 min for 28 h using an automated blood sampling system. Ketamine (5/10/25 mg Á kg) was infused through a subcutaneous cannula at two time points-during the active and inactive period. CORT levels in blood were measured in response to ketamine using a radioimmunoassay. WKY rats displayed robust circadian secretion of corticosterone and was not overly different to Sprague Dawley rats. Ketamine (all doses) significantly increased CORT response at both infusion times. However, a dose dependent effect and marked increase over baseline was observed when ketamine was administered during the inactive phase. Ketamine has a robust and rapid effect on HPA axis function.The timing of ketamine injection may prove crucial for glucocorticoid-mediated action in depression.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.